Skip to main content
SpringerLink
Log in

The Last of the Meningococcus?

  • Conference paper
Hot Topics in Infection and Immunity in Children

Part of the book series: Advances in Experimental Medicine and Biology ((AEMB,volume 549))

  • 243 Accesses

Abstract

Globally, infectious diseases account for 63% of deaths in children under the age of 4 years, with acute respiratory infection (ARI), diarrhea, measles, malaria, and HIV infection accounting for the greatest proportions of deaths (World Health Organisation, 2000). ARI, for example, is believed to result in 2 million deaths in the under-5 age group and over 3.5 million deaths annually overall. By contrast, the burden of meningococcal infection and mortality is far lower, with only 500,000 cases and about 50,000 deaths per year (Tikhomirov et al., 1997).

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 129.00
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 169.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 169.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  • Abdel-Hadi, H., Wooldridge, K., Robinson, K., and Ala’Aldeen, D.A. (2000). Investigation of the potential of App as a vaccine candidate. In P. Rice, F. Sparling, and W. Shafer (eds.), Twelfth International Neisseria Conference, HCC Inc, Galveston, Texas.

    Google Scholar 

  • Ala’Aldeen, D.A., Davies, H.A., and Bordello, S.P. (1994). Vaccine potential of meningococcal FrpB: studies on surface exposure and functional attributes of common epitopes. Vaccine 12, 535–541.

    Article  CAS  Google Scholar 

  • Arumugham, R., Fortuna-Nevin, M., Mountzouros, K., Secor, S., Sharma, M., Gibson, B. et al. (1998). Development of Lipooligosaccharide—Protein conjugate vaccines against Group B Neisseria meningitidis. In The Fifth Conference of the International Endotoxin Society, Santa Fe, p. 52.

    Google Scholar 

  • Booy, R., Habibi, P., Nadel, S., de Munter, C., Britto, J., Morrison, A. et al. (2001). Reduction in case fatality rate from meningococcal disease associated with improved healthcare delivery. Arch. Dis. Child. 85, 386–390.

    Article  PubMed  CAS  Google Scholar 

  • Bredius, R.G., Derkx, B.H., Fijen, C.A., de Wit, T.P., de Haas, M., Weening, R.S. et al. (1994). Fc gamma receptor IIa (CD32) polymorphism in fulminant meningococcal septic shock in children. J. Infect. Dis. 170, 848–853.

    Article  PubMed  CAS  Google Scholar 

  • Cadieux, N., Plante, M., Rioux, C.R., Hamel, J., Brodeur, B.R., and Martin, D. (1999). Bactericidal and cross-protective activities of a monoclonal antibody directed against Neisseria meningitidis NspA outer membrane protein. Infect. Immun. 67, 4955–4959.

    PubMed  CAS  Google Scholar 

  • Carson, S.D., Klebba, P.E., Newton, S.M., and Sparling, P.F. (1999). Ferric enterobactin binding and utilization by Neisseria gonorrhoeae. J. Bacteriol. 181, 2895–2901.

    PubMed  CAS  Google Scholar 

  • Centers for Disease Control and Prevention (2000). Serogroup W-135 meningococcal disease among travelers returning from Saudi Arabia-United States. MMWR 49, 345–346.

    Google Scholar 

  • Christodoulides, M., Brooks, J.L., Rattue, E., and Heckeis, J.E. (1998). Immunization with recombinant class 1 outer-membrane protein from Neisseria meningitidis: influence of liposomes and adjuvants on antibody avidity, recognition of native protein and the induction of a bactericidal immune response against meningococci. Microbiology 144, 3027–3037.

    Article  PubMed  CAS  Google Scholar 

  • Christodoulides, M. and Heckeis, J.E. (1994). Immunization with a multiple antigen peptide containing defined B-and T-cell epitopes: production of bactericidal antibodies against group B Neisseria meningitidis. Microbiology 140, 2951–2960.

    Article  PubMed  CAS  Google Scholar 

  • Claassen, I., Meylis, J., van der Ley, P., Peeters, C., Brons, H., Robert, J. et al. (1996). Production, characterization and control of a Neisseria meningitidis hexavalent class 1 outer membrane protein containing vesicle vaccine. Vaccine 14, 1001–1008.

    Article  PubMed  CAS  Google Scholar 

  • Danielson, L. and Mann, E. (1806). The history of a singular and very mortal disease, which lately made its appearance in Medfield. Med. Agric. Reg. 1, 65.

    Google Scholar 

  • Danve, B., Lissolo, L., Guinet, F., Boutry, E., Speck, D., Cadoz, M. et al. (1998). Safety and immunogenicity of a Neisseria meningitidisgroup B transferrin binding protein vaccine in adults. In X. Nassif, M.J. Quentin-Millet, and M.-K. Taha (eds.), Eleventh International Pathogenic Neisseria Conference. EDK, Paris, Nice, p. 53.

    Google Scholar 

  • Danve, B., Lissolo, L., Mignon, M., Dumas, P., Colombani, S., Schryvers, A.B. et al. (1993). Transferrin-binding proteins isolated from Neisseria meningitidis elicit protective and bactericidal antibodies in laboratory animals. Vaccine 11, 1214–1220.

    Article  PubMed  CAS  Google Scholar 

  • Decosas, J. and Koama, J.B. (2002). Chronicle of an outbreak foretold: meningococcal meningitis W135 in Burkina Faso. Lancet Infect. Dis. 2, 763–765.

    Article  PubMed  Google Scholar 

  • Fijen, C.A., Bredius, R.G., and Kuijper, E.J. (1993). Polymorphism of IgG Fc receptors in meningococcal disease. Ann. Intern. Med. 119, 636.

    PubMed  CAS  Google Scholar 

  • Fijen, C.A., Bredius, R.G., Kuijper, E.J., Out, T.A., De Haas, M., De Wit, A.P. et al. (2000). The role of Fcgamma receptor polymorphisms and C3 in the immune defence against Neisseria meningitidis in complement-deficient individuals. Clin. Exp. Immunol. 120, 338–345.

    Article  PubMed  CAS  Google Scholar 

  • Fijen, C.A., Kuijper, E.J., te Bulte, M.T., Daha, M.R., and Dankert, J. (1999). Assessment of complement deficiency in patients with meningococcal disease in The Netherlands. Clin. Infect. Dis. 28, 98–105.

    Article  PubMed  CAS  Google Scholar 

  • Fredriksen, J.H., Rosenqvist, E., Wedege, E., Bryn, K., Bjune, G., Frøholm, L.O. et al. (1991). Production, characterization and control of MenB-vaccine “Folkehelsa”: an outer membrane vesicle vaccine against group B meningococcal disease. NIPH Ann. 14, 67–79; discussion 79-80.

    PubMed  CAS  Google Scholar 

  • Gomez, J.A., Criado, M.T., and Ferreiros, C.M. (1998). Bactericidal activity of antibodies elicited against the Neisseria meningitidis 37-kDa ferric binding protein (FbpA) with different adjuvants. FEMS Immunol. Med. Microbiol. 20, 79–86.

    Article  PubMed  CAS  Google Scholar 

  • Griffiss, J.M., Brandt, B.L., Broud, D.D., Goroff, D.K., and Baker, C.J. (1984). Immune response of infants and children to disseminated infections with Neisseria meningitidis. J. Infect. Dis. 150, 71–79.

    Article  PubMed  CAS  Google Scholar 

  • Harding, D., Baines, P.B., Brull, D., Vassiliou, V., Ellis, I., Hart, A. et al. (2002). Severity of meningococcal disease in children and the angiotensin-converting enzyme insertion/deletion polymorphism. Am. J. Respir. Crit. Care Med. 165, 1103–1106.

    PubMed  Google Scholar 

  • Hausdorff, W.P., Bryant, J., Paradiso, P.R., and Siber, G.R. (2000). Which pneumococcal serogroups cause the most invasive disease: implications for conjugate vaccine formulation and use, part I. Clin. Infect. Dis. 30, 100–121.

    Article  PubMed  CAS  Google Scholar 

  • Hibberd, M.L., Sumiya, M., Summerfield, J.A., Booy, R., and Levin, M. (1999). Association of variants of the gene for mannose-binding lectin with susceptibility to meningococcal disease. Meningococcal Research Group. Lancet 353, 1049–1053.

    Article  PubMed  CAS  Google Scholar 

  • Johnson, A.S., Gorringe, A.R., Mackinnon, F.G., Fox, A.J., Borrow, R., and Robinson, A. (1999). Analysis of the human Ig isotype response to lactoferrin binding protein A from Neisseria meningitidis. FEMS Immunol. Med. Microbiol. 25, 349–354.

    Article  PubMed  CAS  Google Scholar 

  • Kizil, G., Todd, I., Atta, M., Borriello, S.P., Ait-Tahar, K., and Ala’Aldeen, D.A. (1999). Identification and characterization of TspA, a major CD4(+) T-cell-and B-cell-stimulating Neisseria-specific antigen. Infect. Immun. 67, 3533–3541.

    PubMed  CAS  Google Scholar 

  • Kondaveeti, S., Hibberd, M.L., Booy, R., Nadel, S., and Levin, M. (1999). Effect of the Factor V Leiden mutation on the severity of meningococcal disease. Pediatr. Infect. Dis. J. 18, 893–896.

    Article  PubMed  CAS  Google Scholar 

  • Lapeyssonnie, L. (1963). La meningite cerebro-spinale en Afrique. Bull WHO 28, 3–114.

    Google Scholar 

  • MacLennan, J.M., Shackley, F., Heath, P.T., Deeks, J.J., Flamank, C., Herbert, M. et al. (2000). Safety, immunogenicity, and induction of immunologic memory by a serogroup C meningococcal conjugate vaccine in infants: A randomized controlled trial. JAMA 283, 2795–2801.

    Article  PubMed  CAS  Google Scholar 

  • Maiden, M.C. and Stuart, J.M. (2002). Carriage of serogroup C meningococci 1 year after meningococcal C conjugate polysaccharide vaccination. Lancet 359, 1829–1831.

    Article  PubMed  Google Scholar 

  • Martin, D., Cadieux, N., Hamel, J., and Brodeur, B.R. (1997). Highly conserved Neisseria meningitidis surface protein confers protection against experimental infection. J. Exp. Med. 185, 1173–1183.

    Article  PubMed  CAS  Google Scholar 

  • Miller, E., Salisbury, D., and Ramsay, M. (2001). Planning, registration, and implementation of an immunisation campaign against meningococcal serogroup C disease in the UK: a success story. Vaccine 20(Suppl 1), S58–S67.

    Article  PubMed  Google Scholar 

  • Morley, S.L. and Pollard, A.J. (2001). Vaccine prevention of meningococcal disease, Vaccine 20, 666–687.

    Article  PubMed  CAS  Google Scholar 

  • Munkley, A., Tinsley, C.R., Virji, M., and Heckeis, J.E. (1991). Blocking of bactericidal killing of Neisseria meningitidis by antibodies directed against class 4 outer membrane protein. Microb. Pathog. 11, 447–452.

    Article  PubMed  CAS  Google Scholar 

  • Nadel, S., Newport, M.J., Booy, R., and Levin, M. (1996). Variation in the tumor necrosis factor-alpha gene promoter region may be associated with death from meningococcal disease. J. Infect. Dis. 174, 878–880.

    Article  PubMed  CAS  Google Scholar 

  • Pizza, M., Scarlato, V., Masignani, V., Giuliani, M.M., Arico, B., Comanducci, M. et al. (2000). Identification of vaccine candidates against serogroup B meningococcus by whole-genome sequencing. Science 287, 1816–1820.

    Article  PubMed  CAS  Google Scholar 

  • Plested, J.S., Makepeace, K., Jennings, M.P., Gidney, M.A., Lacelle, S., Brisson, J. et al. (1999). Conservation and accessibility of an inner core lipopolysaccharide epitope of Neisseria meningitidis. Infect. Immun. 67, 5417–5426.

    PubMed  CAS  Google Scholar 

  • Pollard, A.J., Britto, J., Nadel, S., DeMunter, C., Habibi, P., and Levin, M. (1999). Emergency management of meningococcal disease. Arch. Dis. Child. 80, 290–296.

    Article  PubMed  CAS  Google Scholar 

  • Pollard, A.J. and Moxon, E.R. (2002). The meningococcus tamed? Arch. Dis. Child. 87, 13–17.

    Article  PubMed  CAS  Google Scholar 

  • Pollard, A.J. and Scheifele, D. (2001). Meningococcal disease and vaccination in North America. J. Paediatr. Child Health. 37, 20–27.

    Article  Google Scholar 

  • Ramsay, M.E., Andrews, N., Kaczmarski, E.B., and Miller, E. (2001). Efficacy of meningococcal serogroup C conjugate vaccine in teenagers and toddlers in England. Lancet 357, 195–196.

    Article  PubMed  CAS  Google Scholar 

  • Ramsay, M.E., Andrews, N.J., Trotter, C.L., Kaczmarski, E.B., and Miller, E. (2003). Herd immunity from meningococcal serogroup C conjugate vaccination in England: database analysis. BMJ 326,365–366.

    Article  PubMed  Google Scholar 

  • Read, R.C., Camp, N.J., di Giovine, F.S., Borrow, R., Kaczmarski, E.B., Chaudhary, A.G. et al. (2000). An inter-leukin-1 genotype is associated with fatal outcome of meningococcal disease. J Infect. Dis. 182, 1557–1560.

    Article  PubMed  CAS  Google Scholar 

  • Read, R.C., Cannings, C., Naylor, S.C., Timms, J.M., Maheswaran, R., Borrow, R. et al. (2003). Variation within genes encoding interleukin-1 and the interleukin-1 receptor antagonist influence the severity of meningococcal disease. Ann. Intern. Med. 138, 534–541.

    PubMed  CAS  Google Scholar 

  • Richmond, P., Borrow, R., Miller, E., Clark, S., Sadler, F., Fox, A. et al. (1999). Meningococcal serogroup C conjugate vaccine is immunogenic in infancy and primes for memory. J. Infect. Dis. 179, 1569–1572.

    Article  PubMed  CAS  Google Scholar 

  • Rokbi, B., Renauld-Mongenie, G., Mignon, M., Danve, B., Poncet, D., Chabanel, C. et al. (2000). Allelic diversity of the two transferrin binding protein B gene isotypes among a collection of Neisseria meningitidis strains representative of serogroup B disease: implication for the composition of a recombinant TbpB-based vaccine. Infect. Immun. 68, 4938–4947.

    Article  PubMed  CAS  Google Scholar 

  • Rosenqvist, E., Tjade, T., Fr0holm, L.O. and Frasch, C.E. (1983). An ELISA study of the antibody response after vaccination with a combined meningococcal group B polysaccharide and serotype 2 outer membrane protein vaccine. NIPH Ann. 6, 139–149.

    PubMed  CAS  Google Scholar 

  • Rosenstein, N.E., Perkins, B.A., Stephens, D.S., Lefkowitz, L., Cartter, M.L., Danila, R. et al. (1999). The changing epidemiology of meningococcal disease in the United States, 1992-1996. J. Infect. Dis. 180, 1894–1901.

    Article  PubMed  CAS  Google Scholar 

  • Schluter, B., Raufhake, C., Erren, M., Schotte, H., Kipp, F., Rust, S. et al. (2002). Effect of the interleukin-6 promoter polymorphism (-174 G/C) on the incidence and outcome of sepsis. Crit. Care Med. 30, 32–37.

    Article  PubMed  CAS  Google Scholar 

  • Stephens, D.S. and McGee, Z.A. (1981). Attachment of Neisseria meningitidis to human mucosal surfaces: influence of pili and type of receptor cell. J. Infect. Dis. 143, 525–532.

    Article  PubMed  CAS  Google Scholar 

  • Stuber, F., Petersen, M., Bokelmann, F., and Schade, U. (1996). A genomic polymorphism within the tumor necrosis factor locus influences plasma tumor necrosis factor-alpha concentrations and outcome of patients with severe sepsis. Crit. Care Med. 24, 381–384.

    Article  PubMed  CAS  Google Scholar 

  • Tikhomirov, E., Santamaria, M., and Esteves, K. (1997). Meningococcal disease: public health burden and control. World Health Stat. Q. 50, 170–177.

    PubMed  CAS  Google Scholar 

  • Vieusseaux, G. (1805). Memoire sur le maladie qui a regne a Geneve au printemps de 1805. J. Medecine Chirurgie Pharmacie II, 163–165.

    Google Scholar 

  • Virji, M., Makepeace, K., Ferguson, D.J., Achtman, M., and Moxon, E.R. (1993). Meningococcal Opa and Opc proteins: their role in colonization and invasion of human epithelial and endothelial cells. Mol. Microbiol. 10, 499–510.

    Article  PubMed  CAS  Google Scholar 

  • Wang, J.F., Caugant, D.A., Li, X., Hu, X., Poolman, J.T., Crowe, B.A. et al. (1992). Clonal and antigenic analysis of serogroup A Neisseria meningitidis with particular reference to epidemiological features of epidemic meningitis in the People’s Republic of China. Infect. Immun. 60, 5267–5282.

    PubMed  CAS  Google Scholar 

  • Weichselbaum, A. (1887). Ueber die aetiologie der akuten meningitis cerebro-spinalis. Fotschr. Med. 5, 573–583, 620-626.

    Google Scholar 

  • Welch, S.B. and Nadel, S. (2003). Treatment of meningococcal infection. Arch. Dis. Child. 88, 608–614.

    Article  PubMed  CAS  Google Scholar 

  • West, D., Reddin, K., Matheson, M., Heath, R., Funnell, S., Hudson, M. et al. (2001). Recombinant Neisseria meningitidis transferrin binding protein A protects against experimental meningococcal infection. Infect. Immun. 69, 1561–1567.

    Article  PubMed  CAS  Google Scholar 

  • Westendorp, R.G., Hottenga, J.J., and Slagboom, P.E. (1999). Variation in plasminogen-activator-inhibitor-1 gene and risk of meningococcal septic shock. Lancet 354, 561–563.

    Article  PubMed  CAS  Google Scholar 

  • Willis, T. (1684). A description of an epidemical feaver in 1661. In T. Dring (ed.), Practice of Physick, Vol. Treatise VIII. London, pp. 46–54.

    Google Scholar 

  • World Health Organisation. (2000). WHO report on global surveillance of epidemic-prone infectious diseases. Department of Communicable Disease Surveillance and Response, http://www.who.int/emc-documents/sur-veillance/docs/whocdscsrisr2001.html/Meningitis/Meningitis.htm

  • Zollinger, W.D., Moran, E.E., Devi, S.J., and Frasch, C.E. (1997). Bactericidal antibody responses of juvenile rhesus monkeys immunized with group B Neisseria meningitidis capsular polysaccharide-protein conjugate vaccines. Infect. Immun. 65, 1053–1060.

    PubMed  CAS  Google Scholar 

Download references

Authors
  1. Shelley Segal
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Andrew J. Pollard
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. Department of Paediatrics, University of Oxford, Oxford, UK

    Andrew J. Pollard

  2. Southwestern Medical Center, University of Texas, Dallas, Texas, USA

    George H. McCracken Jr.

  3. University of Bristol, Bristol, UK

    Adam Finn

Rights and permissions

Reprints and permissions

Copyright information

© 2004 Science+Business Media New York

About this paper

Cite this paper

Segal, S., Pollard, A.J. (2004). The Last of the Meningococcus?. In: Pollard, A.J., McCracken, G.H., Finn, A. (eds) Hot Topics in Infection and Immunity in Children. Advances in Experimental Medicine and Biology, vol 549. Springer, Boston, MA. https://doi.org/10.1007/978-1-4419-8993-2_27

Download citation

  • DOI: https://doi.org/10.1007/978-1-4419-8993-2_27

  • Publisher Name: Springer, Boston, MA

  • Print ISBN: 978-1-4613-4751-4

  • Online ISBN: 978-1-4419-8993-2

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics

Search

Navigation